Why Yahoo-Tumblr Is...
Health Care: Drugs
Elan Corp PLC (ELN: NYSE)
$12.04 0.37 | 3.17%
05/20/13 - 04:04 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 371.28M | 315.11M | 309.51M | 309.51M | 300.04M | 297.55M | 296.12M |
| Shares Bought | 106.69M | 49.95M | 46.34M | 46.56M | 64.74M | 61.79M | 62.01M |
| Shares Sold | 37.02M | 33.92M | 34.74M | 34.25M | 48.71M | 51.65M | 50.54M |
Portfolios with ELN
- Portfolio NameUser Type
- ContributorMost-Active Stocks for the ...
- ProTPG-Axon Capital
- Contributor22 Biopharma Stocks With Br...
- UserGFNN Stockdiagnostics 13
- ContributorBreakout Stocks Of The Week...
- UserGFNN Stockdiagnostics
- ContributorRelative Strength Trades fo...
- ContributorStocks At New 52-Week Highs...
- ProRobert Bruce
- ContributorTechnical Setups for the We...
Latest ELN Headlines from TheStreet
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- SAC to Pay Record Insider Trading Penalty 03.16.13 | 11:03 am
- Dow Sets Another Record as Stocks Rise 03.11.13 | 04:03 pm
- You Have to Love a Lucrative 'Drug Deal' 02.28.13 | 06:02 am
- Royalty Pharma: Don't Let Elan Piss Away $3 Billion On Stupid Acquisitions 02.25.13 | 09:02 am
- 2 Hot Stocks to Trade (or Not) 02.07.13 | 02:02 pm
- Before the Bell: Feb. 6
02.06.13 | 08:02 am - The Digital Skeptic: Insider Trading? Why Even Bother? 12.04.12 | 08:12 am
- SAC's Alleged Insider Trade Hid in Dark Pools 11.20.12 | 03:11 pm
- The Targacept Secret That Wall Street Doesn't Want You to Know About 09.18.12 | 07:09 am
Press Releases for ELN
- Royalty Pharma Increases Offer For Elan To $12.50 Per Share In All Cash - PR Newswire 05.20.13 | 11:05 am
- Royalty Pharma Submits Formal Cash Offer For Elan Corporation, Plc ("Elan") - PR Newswire 05.02.13 | 07:05 am
- Royalty Pharma Announces Firm Offer To Acquire Elan - PR Newswire 04.15.13 | 07:04 am
- New TYSABRI Data Reaffirm Substantial Efficacy In Treatment Of People With MS And Demonstrate Stability Of Anti-JCV Antibody Status - Business Wire 03.18.13 | 07:03 am
- Elan Discloses Filing Of Share Repurchase Tender Offer Documentation - Business Wire 03.12.13 | 01:03 pm
- Elan Provides Update On Tysabri Transaction And $1bn Share Repurchase - Business Wire 03.08.13 | 04:03 pm
- Elan’s Response To Royalty Pharma Statement Of Today - Business Wire 03.06.13 | 09:03 am
- Elan Announces Further Unlocking Of Value To Benefit Shareholders - Business Wire 03.04.13 | 01:03 am
- Elan Announces The Appointment Of Mr. John Given As General Counsel - Business Wire 02.28.13 | 02:02 am
- Elan’s Response To Indication Of Interest - Business Wire 02.25.13 | 09:02 am
Partner Headlines for ELN
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Alzheimer's keeps frustrating big pharma - MSN Money 05.13.13 | 10:05 am
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Benzinga's Top Pre-Market Gainers - Benzinga 04.12.13 | 09:04 am
- After Hours Most Active for Feb 6, 2013 : T, BMY, FCX, KMI, NOK, HCBK, QQQ, ELN, GMCR, VMED, NWSA, WCRX - NASDAQ 02.06.13 | 09:02 pm
- Stocks Lower In Choppy Trade; Aruba, Trimble Slide - Investor's Business Daily 02.06.13 | 03:02 pm
- Pre-Market Most Active for Feb 6, 2013 : ELN, QQQ, BAC, BBRY, ZNGA, NOK, GSK, VMED, KB, SNY, ARMH, CLDX - NASDAQ 02.06.13 | 01:02 pm
- Biogen Stock Hits New High On Tysabri Buyout - Investor's Business Daily 02.06.13 | 10:02 am
- Alkermes Trades Tightly, Holds In Buying Range - Investor's Business Daily 01.17.13 | 02:01 pm
- Alkermes' Acquisition Proves To Be Game-Changer - Investor's Business Daily 11.30.12 | 05:11 pm
